Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
76-90 of 1541 results
OncoSec reports positive six-month results from Phase II trial of melanoma drug
By PBR Staff Writer
US-based OncoSec Medical has reported positive top-line six-month results from the first Phase II trial of its investigational intratumoral plasmid IL-12 electroporation (pIL-12 EP) monotherapy (ImmunoPulse IL-12) to treat patients with stage III and IV metastatic melanoma.
Automation > IT & Software > News
Basilea launches Zevtera in Germany
By PBR Staff Writer
Switzerland-based Basilea Pharmaceutica has launched its broad-spectrum antibiotic, Zevtera (ceftobiprole medocaril) in Germany to support the treatment of bacterial lung infections.
Automation > IT & Software > News
Foundation Medicine and Flatiron Health to develop data platform to accelerate Precision Medicine for Cancer
Foundation Medicine, and Flatiron Health announced a strategic collaboration to develop a unique, proprietary cloud-based information platform combining genomic and clinical treatment and outcomes data to significantly advance the field of precision medicine for cancer.
Automation > IT & Software > News
Unum Therapeutics begins Phase I trial of ATTCK20 combination therapy
By PBR Staff Writer
US-based Unum Therapeutics has started a Phase I trial designed to evaluate the feasibility, safety and potential efficacy of infusing the ATTCK20 combination therapy in patients with B-cell malignancies and persistent disease following standard therapy.
Automation > IT & Software > News
CareNet joins Indegene partnership network to accelerate growth in Japanese markets
Indegene, a leading global provider of clinical, commercial, and marketing solutions to global life science, pharmaceutical, and healthcare organizations, announced a partnership with Tokyo-based pharmaceutical sales support and marketing research services company CareNet, to mutually expand presence in Japan.
Automation > IT & Software > News
Cell MedX acquires Proprietary Technology to treat diabetes and related ailments
Cell MedX has completed the acquisition of a proprietary technology for the treatment of diabetes and related ailments from the inventors of the Technology, Jean Arnett and Bradley Hargreaves.
Automation > IT & Software > News
UC San Francisco, OncoSec Medical to evaluate investigational combination of ImmunoPulse and Anti-PD-1 treatment
OncoSec Medical, a company developing DNA-based intratumoral cancer immunotherapies, has entered a clinical collaboration with the University of California, San Francisco (UCSF), to evaluate the safety, tolerability and efficacy of the combination of KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, and OncoSec’s ImmunoPulse (intratumoral IL-12) in metastatic melanoma.
Automation > IT & Software > News
Arch Biopartners completes clinical development plan for MetaMx
Arch Biopartners Inc has now completed a Clinical Development Plan (CDP) to prepare a human trial for MetaMx, the Company's brain tumour targeting technology.
Automation > IT & Software > News
Synthon doses first patient in Phase I trial of cancer drug SYD985
By PBR Staff Writer
Synthon Biopharmaceuticals (Synthon) has started dosing patients with its investigational anti-HER2 antibody-drug conjugate (ADC), SYD985, in a Phase I trial to treat metastatic solid tumors.
Automation > IT & Software > News
Trimel announces issuance of additional patent covering NATESTO
Trimel Pharmaceuticals announced that its technology partner Mattern Pharma AG has been granted an additional United States Patent in respect of NATESTO and its proprietary nasal gel technology.
Automation > IT & Software > News
Yabao, MRC Technology to develop new therapeutics in China for Parkinson's disease
By PBR Staff Writer
China-based Yabao Pharmaceutical has entered into an exclusive license with MRC Technology, a UK-based medical research charity, to discover, develop and commercialise new products targeting a kinase target for neurodegeneration to treat Parkinson's disease.
Automation > IT & Software > News
Aspira to distribute Nagase's unnatural amino acids for next-generation drug candidate development
Nagase America is pleased to announce a partnership with Aspira Scientific for the distribution of Nagase's portfolio of unnatural amino acids in North America.
Automation > IT & Software > News
Medidata, TransCelerate report findings of joint research initiative on clinical trial site monitoring methods
Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, announced the results of a data-driven analysis conducted in collaboration with TransCelerate BioPharma, which assesses the value of source document verification (SDV) in a risk-based approach to clinical trial site monitoring.
Automation > IT & Software > News
Intellia announces $15m in funding to develop therapeutic products using CRISPR-Cas9 Gene Editing Technology
Intellia Therapeutics, a new company formed to develop therapeutic products using CRISPR-Cas9 technology for gene editing and repair, announced it has closed a Series A investment round with $15 million in financing led by Atlas Venture and Novartis.
Automation > IT & Software > News
Aphios gets US patent for Nanotechnology co-encapsulation of combination drugs and drug products
Aphios has been granted United States Patent No. 8,637,074 B2 entitled “Methods for Co-Encapsulation of Combination Drugs and Co-Encapsulated Drug Product,” for its green nanoencapsulation technology.
Automation > IT & Software > News
76-90 of 1541 results